Botulinum toxin type A prophylactic treatment for episodic migraine using a modified follow-the-pain treatment paradigm: A randomized, double-blind, placebo controlled, phase II study

被引：0
|
作者：
Aurora, SK
Gawel, M
Brandes, J
Pokta, S
VanDenburgh, AM
机构：
[1] Swedish Pain Ctr, Seattle, WA USA
[2] Sunnybrook Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
[3] Nashville Neurosci Grp PC, Nashville, TN USA
[4] Allergan Pharmaceut Inc, Irvine, CA USA
来源：
HEADACHE | 2005年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：825 / 826
页数：2
相关论文
共 50 条
  • [41] Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
    Giorgio Sandrini
    Armando Perrotta
    Cristina Tassorelli
    Paola Torelli
    Filippo Brighina
    Grazia Sances
    Giuseppe Nappi
    The Journal of Headache and Pain, 2011, 12 : 427 - 433
  • [42] Early botulinum toxin treatment for spastic pes equinovarus - a randomized double-blind placebo-controlled study
    Fietzek, U. M.
    Kossmehl, P.
    Schelosky, L.
    Ebersbach, G.
    Wissel, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (08) : 1089 - 1095
  • [43] Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
    Sandrini, Giorgio
    Perrotta, Armando
    Tassorelli, Cristina
    Torelli, Paola
    Brighina, Filippo
    Sances, Grazia
    Nappi, Giuseppe
    JOURNAL OF HEADACHE AND PAIN, 2011, 12 (04): : 427 - 433
  • [44] A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches
    Relja, M.
    Poole, A. C.
    Schoenen, J.
    Pascual, J.
    Lei, X.
    Thompson, C.
    CEPHALALGIA, 2007, 27 (06) : 492 - 503
  • [45] Treatment of pain attributed to plantar fasciitis with botulinum toxin A: A short-term, randomized, placebo-controlled, double-blind study
    Babcock, MS
    Foster, L
    Pasquina, P
    Jabbari, B
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (09) : 649 - 654
  • [46] Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial
    Wu, Chuan-Jie
    Lian, Ya-Jun
    Zheng, Ya-Ke
    Zhang, Hai-Feng
    Chen, Yuan
    Xie, Nan-Chang
    Wang, Li-Jun
    CEPHALALGIA, 2012, 32 (06) : 443 - 450
  • [47] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Bo Hu
    Gang Li
    Xiaohong Li
    Shan Wu
    Tingmin Yu
    Xiang Li
    Hongru Zhao
    Zhihua Jia
    Junpeng Zhuang
    Shengyuan Yu
    The Journal of Headache and Pain, 2022, 23
  • [48] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Hu, Bo
    Li, Gang
    Li, Xiaohong
    Wu, Shan
    Yu, Tingmin
    Li, Xiang
    Zhao, Hongru
    Jia, Zhihua
    Zhuang, Junpeng
    Yu, Shengyuan
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [49] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [50] Treatment of lateral epicondylitis with botulinum toxin. A randomized, double-blind, placebo-controlled trial
    Wong, SM
    Hui, ACF
    Tong, PY
    Poon, DWF
    Yu, E
    Wong, LKS
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (11) : 793 - 797
12345